RE:RE:RE:RE:Looks like another gapSwingtrader2 wrote: They need approval for masks to justify the market cap.
300m market cap needs earnings to justify??
Investors get too optimistic and too pessimistic, I try to take each of those extremes and invest to profit from those emotional moves. When I see people saying 65 Trillion market cap, $146 and $100 share prices I see too much optimism. If I'm wrong so be it; a fool and his money are soon parted.
2.30ish seems like a fair price to pay when I do my "napkin math".
A biotech stock doesn't need earnings to reach a market cap of 300M. Many of them have a Market Cap of 1B+ without revenue. And what I can see is that ZEN is becoming a biotech, or at least will find a partner in this field. What they communicated in recent days is huge. You can't compare ZEN today with ZEN 6 months ago. With this product in the pipeline, they deserve a whole new valuation. Given the promise, this valuation has to be high. Now of course we are just at the beginning. A lot of work needs to be done to make sure Graphene is safe and effective for humans. And this usually takes years (Covid19 vaccines are an exception).